Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.4 (
deaminase
)
5,113
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mammalian
SIRT7
is a member of the sirtuin family that regulates multiple biological processes including genome stability, metabolic pathways, stress responses, and tumorigenesis.
SIRT7
has been shown to be important for ribosome biogenesis and transcriptional regulation.
SIRT7
knockout mice exhibit complications associated with fatty liver and increased aging in hematopoietic stem cells. However, the molecular basis for its biological function remains unclear, in part due to the lack of efficient enzymatic activity in vitro. Previously, we have demonstrated that double-stranded DNA could activate
SIRT7
's deacetylase activity in vitro, allowing it to deacetylate H3K18 in the context of chromatin. Here, we show that RNA can increase the catalytic efficiency of
SIRT7
even better and that
SIRT7
can remove long chain fatty acyl groups more efficiently than removing acetyl groups. Truncation and mutagenesis studies revealed residues at both the amino and carboxyl termini of
SIRT7
that are involved in RNA-binding and important for activity. RNA immunoprecipitation-sequencing (RIP-seq) identified ribosomal RNA (rRNA) as the predominant RNA binding partner of
SIRT7
. The associated RNA was able to effectively activate the deacetylase and defatty-
acylase
activities of
SIRT7
. Knockdown of
SIRT7
increased the lysine fatty acylation of several nuclear proteins based on metabolic labeling with an alkyne-tagged fatty acid analog, supporting that the defatty-
acylase
activity of
SIRT7
is physiologically relevant. These findings provide important insights into the biological functions of
SIRT7
, as well as an improved platform to develop
SIRT7
modulators.
...
PMID:SIRT7 Is an RNA-Activated Protein Lysine Deacylase. 2799 15